Biokind Healthcare Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 11-01-2025
- Paid Up Capital ₹ 0.10 M
as on 11-01-2025
- Company Age 21 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.00 M
as on 11-01-2025
- Revenue -9.76%
(FY 2020)
- Profit -30.45%
(FY 2020)
- Ebitda 19.02%
(FY 2020)
- Net Worth 75.73%
(FY 2020)
- Total Assets 7.75%
(FY 2020)
About Biokind Healthcare
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.00 M.
Rupen Shah, Sandip Shah, Neil Shah, and One other member serve as directors at the Company.
- CIN/LLPIN
U24231GJ2003PTC042848
- Company No.
042848
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Sep 2003
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Biokind Healthcare Private Limited offer?
Biokind Healthcare Private Limited offers a wide range of products and services, including Common Disease Medicines, Pharmaceutical Tablets, Pain Relief Drugs & Pharmaceuticals, Diclofenac, Cardiovascular Drugs & Medication, Antianginal Drugs, Antihistamines, Nutraceuticals & Dietary Supplements, Mineral Supplement, Pharmaceutical Medicine.
Who are the key members and board of directors at Biokind Healthcare?
Board Members(4)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Rupen Shah | Director | 02-Sep-2003 | Current |
Sandip Shah | Director | 02-Sep-2003 | Current |
Neil Shah | Director | 29-Nov-2016 | Current |
Aneri Shah | Director | 29-Nov-2016 | Current |
Financial Performance of Biokind Healthcare.
Biokind Healthcare Private Limited, for the financial year ended 2020, experienced Minor drop in revenue, with a 9.76% decrease. The company also saw a substantial fall in profitability, with a 30.45% decrease in profit. The company's net worth Soared by an impressive increase of 75.73%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Biokind Healthcare?
In 2020, Biokind Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Hdfc Bank Limited Creation Date: 07 Jun 2013 | ₹1.00 M | Open |
How Many Employees Work at Biokind Healthcare?
Biokind Healthcare has a workforce of 27 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biokind Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biokind Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.